One of the most promising is its cardiovascular disease therapy candidate CTX310, a single-treatment gene therapy that has ...
Supply is outstripping demand for life sciences, but AI and new biotech could help absorb some of the new space, according to ...
The Oligonucleotide Cdmo Market plays a critical role in supporting modern industries by providing scalable, compliant, and cost-effective manufacturing solutions. It ensures the timely supply of ...
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
Allied Market Research published a report, titled, "Pyrogen Testing Market by Product and Service (Reagents & Kits, Instruments, and ...
Legend Biotech Corp (NASDAQ:LEGN) is one of the 13 Best Revenue Growth Stocks to Buy Right Now. In a board shakeup last month ...
Two U.S. senators this week introduced a bill that would create new rules around the sale of synthetic gene sequences that could be used to create bioweapons.
SAN FRANCISCO, Feb 4 (Reuters) - Two U.S. senators this week introduced a bill that would create new rules around the sale of synthetic gene sequences that could be used to create bioweapons.
The MarketWatch News Department was not involved in the creation of this content. Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in ...
Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in 2026 and beyond PISCATAWAY, N.J., Jan. 29, 2026 /PRNewswire/ -- GenScript Biotech ...